FDA Set to Approve 1,000+ Clinical AI Algorithms
FDA plans to clear numerous AI algorithms, enhancing healthcare through advanced technology regulation and streamlined processes.
- Latest
- Trending
FDA plans to clear numerous AI algorithms, enhancing healthcare through advanced technology regulation and streamlined processes.
Seagate's innovation and strategic acquisitions fuel its leading position and growth potential in the data storage industry.
Recursion Pharmaceuticals merges with Exscientia to revolutionize drug discovery, bringing new treatments to market more quickly.
Recursion Pharmaceuticals acquires Exscientia to enhance AI drug discovery, potentially saving millions in drug development costs.
Exscientia merges into Recursion to form a $850 million AI drug discovery powerhouse, focusing on oncology and rare diseases.
Discover this week’s top tech stories: AI safe superintelligence, AI drug discovery, Starlink Mini, Apple's cheaper Vision headset, and more! ...
America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
Tempus AI sold 11M shares at $37 each, launched in 2015, focuses on medical testing, with revenue growth from $320.7M ...
The U.S. lacks AI regulations, but is making progress in implementing safeguards. The Biden Administration introduced new guidance measures for ...
South Korean conglomerate LG Corp. plans to invest $10 billion in artificial intelligence and battery production for electric vehicles.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.